Pneumoconiosis other imaging findings

Jump to navigation Jump to search

Pneumoconiosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumoconiosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pneumoconiosis other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumoconiosis other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumoconiosis other imaging findings

CDC on Pneumoconiosis other imaging findings

Pneumoconiosis other imaging findings in the news

Blogs on Pneumoconiosis other imaging findings

Directions to Hospitals Treating Pneumoconiosis

Risk calculators and risk factors for Pneumoconiosis other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD

Overview

FDG-PET scan may be helpful in the diagnosis of pneumoconiosis. Findings on an FDG-PET scan can help differentiate between benign and malignant lesions. [1]

Other Imaging Findings

FDG-PET scan (Fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) scans) may be helpful in the diagnosis of pneumoconiosis. Findings on an FDG-PET scan suggestive of/diagnostic of pneumoconiosis include helping to differentiate between progressive massive fibrosis in pneumoconiosis and lung cancer. [2] However, there is a high rate of false positives and CT scan is a better option. [3] [4] [5]

References

  1. Choi EK, Park HL, Yoo IR, Kim SJ, Kim YK (2020). "The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients". Eur Radiol. 30 (1): 442–451. doi:10.1007/s00330-019-06342-1. PMID 31338654.
  2. Chung SY, Lee JH, Kim TH, Kim SJ, Kim HJ, Ryu YH (2010). "18F-FDG PET imaging of progressive massive fibrosis". Ann Nucl Med. 24 (1): 21–7. doi:10.1007/s12149-009-0322-9. PMID 19937406.
  3. Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.1097/JTO.0b013e31819d4778 Check |pmid= value (help).
  4. Capitanio S, Nordin AJ, Noraini AR, Rossetti C (2016). "PET/CT in nononcological lung diseases: current applications and future perspectives". Eur Respir Rev. 25 (141): 247–58. doi:10.1183/16000617.0051-2016. PMID 27581824.
  5. Joshi JM, Barve KS, Basu S (2012). "Pulmonary nodules with cavitary mass in a flour mill worker". J Postgrad Med. 58 (4): 328–30. doi:10.4103/0022-3859.105485. PMID 23298939.

Template:WH Template:WS